75
41
Growth Score
-6 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
337417
Synthon is a company committed to delivering affordable medicines through innovative science.
Acquired by 
Goldman Sachs Asset Management
- Anish Mehta: CEO
About the Company
Good health and a happy life is something all people rightly aspire to. They believe everyone on the planet deserves access to quality health care.
Finding affordable solutions to today's health care challenges demands cutting-edge science, highly talented and motivated people and above all the ability to innovate. Innovation and continuous
improvement are the heartbeat of their company.
Their mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, and new biological and new chemical entities.
